Dr. Masters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4701 Ogletown Stanton Rd
Suite 2200
Newark, DE 19713Phone+1 302-366-1200Fax+1 302-366-1700
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1993 - 1996
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1990 - 1993
- Northwestern University The Feinberg School of MedicineClass of 1990
Certifications & Licensure
- DE State Medical License 2003 - 2025
- IL State Medical License 1993 - 2005
- PA State Medical License 1992 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2014
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Start of enrollment: 1999 Aug 01
- Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 1999 Aug 01
- Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2002 Oct 04
- Join now to see all
Publications & Presentations
PubMed
- 1313 citationsStandard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage I...Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein
The Lancet. Oncology. 2015-02-01 - 265 citationsLong-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.Jeffrey D. Bradley, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein
Journal of Clinical Oncology. 2020-03-01 - 115 citationsTherapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab GovitecanRebecca S. Heist, Michael J. Guarino, Gregory A. Masters, W. Thomas Purcell, Alexander Starodub
Journal of Clinical Oncology. 2017-05-26
Journal Articles
- Unique Pattern of Neutrophil Migration and Function During Tumor ProgressionNeil Hockstein, Charles Mulligan, Robert H Vonderheide, Gregory Masters, Nature
Press Mentions
- Guideline Backs First-Line Anti-PD-1/L1 Therapy in NSCLCJanuary 29th, 2020
- ASCO Updates Treatment Guidelines for Advanced NSCLCAugust 15th, 2017
- Health Tips Health Risks of Oral SexFebruary 1st, 2017
- Join now to see all
Committees
- Co-Chair, Update Committee of the ASCO NSCLC Expert Panel, American Society of Clinical Oncology 2015 - Present
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: